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EVIDENCE BASED NEURO-ONCOLOGY
Depression in adult patients with primary brain tumours: a review of
independent risk factors
Anum Sadruddin Pidani, Aaida Mumtaz Rao, Muhammad Shahzad Shamim

Abstract

are reviewed below:

Depression is considered an under-diagnosed problem,
especially in patients with malignancies. Patients with
brain tumours in particular, have a relatively higher risk of
developing depression, which is multifactorial. Herein,
the authors review the recent literature on the prevalence
of depression in patients with brain tumours, and explore
the various risk factors involved.

Age: Other than one cohort study that reported younger
patients to be at higher risk of developing depression, no
other study has supported this notion.8 Here, we must
mention that this review does not include paediatric
patients.
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Introduction
Global data suggests that depression is present in up to
25% of all oncological patients, with higher rates in Asian
countries.1 In Pakistan, up to 52% of patients with
malignancies may have some form of depression.2
Primary brain tumours are ranked highest among
malignancies that lead to emotional and psychological
impact on patients.3 Diagnosing depression in brain
tumour patients is relatively a challenging task as it is
difficult to differentiate the actual cause of depression in
these patients. Apparently, most symptoms of depression
may be a consequence of involvement of white matter
tracts, which can potentially lead to criterion
contamination for the diagnosis of secondary
depression.4

Review of Literature
It is estimated that 15% to 40% of all brain tumour
patients suffer from depression, with highest rates among
those with glioma.5 A systematic review based on 42
observational studies with 25 distinct self-reported
diagnostic tools (scales) reported the prevalence of
depression in glioma patients may range from 0 to 93%
with a median prevalence of 27%.6 Another prospective
cohort study with the largest sample size to date (n=155)
reported that 20% of all glioma patients become clinically
depressed within 8 months of diagnosis.7
The various factors related to depression in these patients
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Gender: Five studies report a positive association
between depression and female sex, especially those
concerning low-grade tumours (I and II). However, 10
studies report no such association, especially the studies
which have included high-grade (III and IV) tumours.
Marital status: Although marital status was not found to
be statistically significant as a factor related to depression,
the trends showed greater prevalence of depression
among unmarried and widowed patients.9
Past psychiatric history: Two studies report past
psychiatric history to be positively associated with
depression in the course of illness, especially when
expected survival is short. However, two other studies
reported no such association.10 Here we must mention
that literature suggests that relapse of depression and
other psychiatric disorders can occur with extreme life
events and it is understandable that patients diagnosed
with primary brain tumour often end up in relapse.
Functional status: Functional class is one of the most
important precursor of depression among primary brain
tumour patients.7 Individuals who scored below 70 at KPS
scale indicating low functionality (class III & IV) have
consistently scored higher in self-evaluating depression
scale.8
Education level: Studies report that individuals with
college level education are less likely to develop
depression than those with lower educational level.9
Occupation: Occupation is an important socioeconomic determinant which may have a role in
depression among primary brain tumour patients.9
Three studies out of 42 reported role of employment in
the development of depression out of which one
showed positive association.
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Figure (a,b): Pre and post operative MRI brain with contrast, axial sections, showing complete excision of a large frontal meningioma that was diagnosed due to symptoms of
depression.

Tumour grade: In most studies, tumour grade was not
associated with depression. Patients with all grades had
similar risk for depressive symptoms. However, a study
conducted by Arnold and associates reported low
prevalence of depression in grade I tumour compared to
other grades (II, III, and IV).
Tumour location: Five studies found no association
between location of tumour and depression, although
one study reported frontal lobe as a tumour location that
is an independent indicator of depression.6 Another study
reported the association of left hemispheric tumour and
depression, especially in female patients.10
Timing from Surgery: Two studies reported decreasing
trends in depression level, three months from the first
surgery, although other studies with longitudinal follow
up (1 to 6 years) reported increase in levels of depression
as the duration of disease increases.8 Overall, studies
suggest that depression levels tend to fluctuate over
time and the trend remains inconsistent.
Anti-epileptic drugs and steroids: Antiepileptic drugs
have been shown to have a direct association with
Vol. 68, No. 4, April 2018

depression in patients with primary brain tumour.11 Use
of steroids is also reported to be associated in mediating
depressive symptoms among primary brain tumour
patients.12
Chemotherapy: Higher levels of depression have been
reported in female patients during chemotherapy.13 Side
effects of chemotherapy such as alopecia and skin related
changes may be the reason for this association.
Cost: The reviewers did not find any studies that analyzed
the cost of care as a factor associated with depression.
This may not be a major problem in higher income
countries, where healthcare is not usually out-of-pocket,
but for developing countries like Pakistan, this remains an
important area of research.

Conclusion
Depression among patients with primary brain tumour is
common, although in most cases it may be treatable.
Early diagnosis is critical. Identification of high risk
patients can enable health care providers to screen such
patients earlier and more frequently. There is a need to
conduct further researches to identify more factors that
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could be associated with depression among patients with
primary brain tumours.
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